General Information of the Compound
| Compound ID |
CP0554211
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S,6S,14S)-6-acetamido-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-3-(2-methylsulfanylethyl)-2,5,8-trioxo-1,4,9-triazacyclotetradecane-14-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H43N9O6S2
|
||||||||||||||||||
| Molecular Weight |
689.865
|
||||||||||||||||||
| Canonical SMILES |
CSCC[C@@H]1NC(=O)[C@H](CC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)c1nc2ccccc2s1)NC(C)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H43N9O6S2/c1-17(40)35-22-16-24(41)33-13-6-5-9-20(37-27(44)21(12-15-46-2)38-28(22)45)26(43)36-19(10-7-14-34-30(31)32)25(42)29-39-18-8-3-4-11-23(18)47-29/h3-4,8,11,19-22H,5-7,9-10,12-16H2,1-2H3,(H,33,41)(H,35,40)(H,36,43)(H,37,44)(H,38,45)(H4,31,32,34)/t19-,20-,21-,22-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NEDJZMSZNJMQAV-CMOCDZPBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound